The post-traumatic stress disorder (PTSD) treatment market is estimated to be valued at USD 18.5 billion in 2025 and is projected to reach USD 30.2 billion by 2035, registering a compound annual growth rate of 5.0% over the forecast period. The antidepressants segment is expected to account for 48.60% of total revenue by 2025, making it the leading drug class in the market.
Several factors are driving market expansion. Rising awareness of mental health conditions, increased diagnosis rates, and the availability of advanced therapeutic options are contributing to growth. Growing investments in neuroscience research and introduction of novel therapies are strengthening treatment accessibility. Governments and healthcare systems are implementing supportive policies to improve patient access to mental health care services. Technological advancements in telemedicine and digital health platforms are making treatment delivery more efficient and widespread. Additionally, a reduction in stigma surrounding mental health is encouraging more individuals to seek professional help.
In North America, PTSD affects an estimated 8 million adults every year, with the condition more prevalent among veterans, first responders, and survivors of sexual assault or domestic violence. North America is expected to possess a 43% market share for the PTSD market in 2025. In the United Kingdom, PTSD affects an estimated 4% of the population. Europe is expected to possess a 42% market share for 2025. According to the National Institute of Mental Health, an estimated 7.7 million adults in the United States have PTSD.
The retail pharmacies segment is projected to hold 56.30% of total market revenue by 2025, positioning it as the dominant distribution channel. Treatment options include pharmacological interventions, psychotherapy—such as cognitive behavioral therapy, prolonged exposure therapy, and eye movement desensitization and reprocessing—self-help strategies, and support groups.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.futuremarketinsights.com/reports/post-traumatic-stress-disorder-treatment-market